Health Condition 1: E889- Metabolic disorder, unspecified
Conditions
Interventions
Intervention1: SBTD AND 5:2 TYPE OF INTERVENTION: Groups will be divided using the following interventional methods:
RCT1: First group (SBTD arm): [Medication + Super food Based Therapeutic Diet +
Ex
Sponsors
UNIVERSITY GRANTA COMMISSION NFOBC
Eligibility
Inclusion criteria
Inclusion criteria: - Adult age group (18-65 years) - Diagnosed with NAFLD by physicians. - A valid consent
Exclusion criteria
Exclusion criteria: -NAFLD patients with cirrhosis or hepatocellular carcinoma - Pregnant and lactating lady. - People with other causes of liver disease will be excluded (alcohol, viral, genetic, hepatic viruses A-E, etc.). - Patients who consume more than 20 g of alcohol per day (10 g per day in men) - Those on drugs that can induce fatty liver or insulin sensitization, such as estrogens, amiodarone, methotrexate, tamoxifen, glitazones, and metformin, were also excluded from the study. - Bedridden individuals
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction of hepatic steatosis (steatohepatitis) as measured by a fibroscan and USG abdomenTimepoint: Within 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Get knowledge about the importance of indigenously available superfoods and their rational uses, as well as their impact on the bodyTimepoint: in 3 years Through out study;Reduction of inflammation (via liver enzyme reduction); reduction of fibrosis (via fibro-scan decrease in liver stiffness)Timepoint: Within 6 months after interventions given | — |
Countries
India
Contacts
Public ContactDr Girish Pati
Institute of Medical Sciences and SUM Hospital, SOA University, Bhubaneswar
Outcome results
None listed